Study on Mavorixafor for Patients with Chronic Neutropenia Experiencing Recurrent or Serious Infections
- Substances:Mavorixafor
Spain- Participants:0–17 years · 18–64 years · 65+ years
- Substances:Mavorixafor
- Sponsor:X4 Pharmaceuticals Inc.
Rare diseases
Investigational molecules
Locations
Back to Spain303 clinical trials in Las Palmas De Gran Canaria, Spain across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
SpainThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on multiple cancer types, including studies of novel therapeutic approaches for leukemia, lung cancer, and breast cancer.
Research emphasizes combination therapies and targeted treatments to improve patient outcomes.
Comprehensive studies investigating treatments for inflammatory diseases and autoimmune disorders, with particular focus on novel biological therapies.
Advanced clinical trials evaluating new therapeutic approaches for chronic inflammatory conditions.
Cutting-edge research in immunotherapy and allergic conditions, exploring new treatment modalities and therapeutic combinations.
Innovative approaches focusing on immune system modulation for various conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.